Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202)

NCT00096460 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT00096460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00096460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2/3
Overall status
Terminated
Start date
August 31, 2004
Completion date
March 31, 2009
Enrollment
30 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, recurrent grade 1 follicular lymphoma, recurrent grade 2 follicular lymphoma, recurrent grade 3 follicular lymphoma